相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nanoliposome-based antibacterial drug delivery
Somayeh Hallaj-Nezhadi et al.
DRUG DELIVERY (2015)
Evolution toward high-level fluoroquinolone resistance in Francisella species
Vivien Sutera et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Cytosporone B, an Inhibitor of the Type III Secretion System of Salmonella enterica Serovar Typhimurium
Jianfang Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Targeting the Cytokine Storm for Therapeutic Benefit
Riccardo V. D'Elia et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Antimicrobial susceptibility of Francisella tularensis subsp holarctica strains from Hungary, Central Europe
Zsuzsa Kreizinger et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Assessment of antimicrobial peptide LL-37 as a post-exposure therapy to protect against respiratory tularemia in mice
Helen C. Flick-Smith et al.
PEPTIDES (2013)
A case of oculoglandular tularemia resistant to medical treatment
Muhammet Kosker et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Prevalence of Francisella tularensis and Francisella-Like Endosymbionts in the Tick Population of Hungary and the Genetic Variability of Francisella-Like Agents
Zsuzsa Kreizinger et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2013)
Treatment of Tularemia in Pregnant Woman, France
Charlotte Dentan et al.
EMERGING INFECTIOUS DISEASES (2013)
The Class A β-Lactamase FTU-1 Is Native to Francisella tularensis
Nuno T. Antunes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Standardized broth microdilution antimicrobial susceptibility testing of Francisella tularensis subsp holarctica strains from Europe and rare Francisella species
Enrico Georgi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Post-exposure immunization against Francisella tularensis membrane proteins augments protective efficacy of gentamicin in a mouse model of pneumonic tularemia
Marjorie D. Sutherland et al.
VACCINE (2012)
Nasal Acai Polysaccharides Potentiate Innate Immunity to Protect against Pulmonary Francisella tularensis and Burkholderia pseudomallei Infections
Jerod A. Skyberg et al.
PLOS PATHOGENS (2012)
Human Tularemia in France, 2006-2010
Max Maurin et al.
CLINICAL INFECTIOUS DISEASES (2011)
Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37
Peter G. Barlow et al.
PLOS ONE (2011)
Immunity to Francisella
Siobhan C. Cowley et al.
FRONTIERS IN MICROBIOLOGY (2011)
Bioavailability and Efficacy of Levofloxacin against Francisella tularensis in the Common Marmoset (Callithrix jacchus)
Michelle Nelson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Effect of the antimicrobial peptide LL-37 on Toll-like receptors 2-, 3-and 4-triggered expression of IL-6, IL-8 and CXCL10 in human gingival fibroblasts
T. Into et al.
CELLULAR IMMUNOLOGY (2010)
Toll-Like Receptor 3 Agonist Protection against Experimental Francisella tularensis Respiratory Tract Infection
Richard B. Pyles et al.
INFECTION AND IMMUNITY (2010)
Phenotypic and genetic characterization of macrolide resistance in Francisella tularensis subsp. holarctica biovar I
Brieuc Gestin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Investigating an Airborne Tularemia Outbreak, Germany
Anja M. Hauri et al.
EMERGING INFECTIOUS DISEASES (2010)
Francisella tularensis Infection-Derived Monoclonal Antibodies Provide Detection, Protection, and Therapy
Anne G. Savitt et al.
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Water-Borne Outbreak of Oropharyngeal and Glandular Tularemia in Georgia: Investigation and Follow-up
N. Chitadze et al.
INFECTION (2009)
NK cells activated in vivo by bacterial DNA control the intracellular growth of Francisella tularensis LVS
Karen L. Elkins et al.
MICROBES AND INFECTION (2009)
Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia
Meliha Meric et al.
APMIS (2008)
Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections
Margaret R. Hammerschlag et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Tularemia: current diagnosis and treatment options
Matthew J. Hepburn et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2008)
Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis
Girish S. Kirimanjeswara et al.
IMMUNOLOGICAL REVIEWS (2008)
Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia
Annalisa Lembo et al.
JOURNAL OF IMMUNOLOGY (2008)
Levofloxacin rescues mice from lethal intra-nasal infections with virulent Francisella tularensis and induces immunity and production of protective antibody
Gary R. Klimpel et al.
VACCINE (2008)
Generation and characterization of hybridorna antibodies for immunotherapy of tularemia
Zhaohua Lu et al.
IMMUNOLOGY LETTERS (2007)
Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis
Girish S. Kirimanjeswara et al.
JOURNAL OF IMMUNOLOGY (2007)
Active suppression of the pulmonary immune response by Francisella tularensis Schu4
Catharine M. Bosio et al.
JOURNAL OF IMMUNOLOGY (2007)
Vaccines and therapeutic agents for tularemia
Rhonda KuoLee et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2007)
Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin
J. Steward et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice
T Piercy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains
H Tomaso et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
The complete genome sequence of Francisella tularensis, the causative agent of tularemia
P Larsson et al.
NATURE GENETICS (2005)
Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp novicida infection
MA Pammit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
In vitro susceptibility of field isolates of Francisella tularensis subsp holarctica recovered in Spain to several antimicrobial agents
NG del Blanco et al.
RESEARCH IN VETERINARY SCIENCE (2004)
Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection
JP Wong et al.
JOURNAL OF CONTROLLED RELEASE (2003)
The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses
MG Scott et al.
JOURNAL OF IMMUNOLOGY (2002)
In vitro susceptibility to quinolones of Francisella tularensis subspecies tularensis
A Johansson et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2002)
Treatment of tularemia with levofloxacin
EA Aranda
CLINICAL MICROBIOLOGY AND INFECTION (2001)
Bactericidal activities of antibiotics against intracellular Francisella tularensis
M Maurin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals
I Ikäheimo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
分享论文
